These results support that GSK-3α might function independent of the β-catenin stabilization in lung cancer but further analysis needs to be completed to fully understand the roles of GSK-3α and GSK-3β in β -catenin stabilization in lung cancer. This evidence concerns the gene GSK3A and lung cancer.